OBJECTIVES: Endoscopic eradication therapy is used to treat mucosal neoplasms in
Barrett's esophagus, but cannot cure cancers that have metastasized to lymph nodes. The …

Esophageal cancer can be divided in squamous-cell cancer (SCC) and adenocarcinoma
(Barrett cancer: AEG I) by histopathology. However, most studies do not differentiate …

Background & Aims: In view of the mortality and morbidity rates of esophagectomy and the
relatively large group of inoperable patients, local therapeutic techniques are required for …

Objective: The objective of this study was to assess the prevalence and pattern of lymphatic
spread in patients with early squamous cell and adenocarcinoma and identify prognostic …

From the epidemiologic and therapeutic point of view, tumours of the gastroesophageal
junction should be classified either as adenocarcinoma of the distal esophagus (Type I), true …

Objective The study objective was to evaluate the efficacy and toxicity of chemoradiotherapy
with 5-fluorouracil (5-FU) plus cisplatin in patients with Stage I esophageal squamous cell …

Adenocarcinoma of the esophagus, or GEJ, has a poor prognosis. Early lesions [ie high
grade dysplasia (HGD) or T1-carcinoma] are potentially curable. Local endoscopic therapies …

Background Esophageal carcinoma is among the cancers with the worst prognosis. Real
chances for cure depend on both early recognition and early treatment. The ability to predict …

BACKGROUND: Endoscopic techniques are being developed for the local treatment of early
stage esophageal cancer. However, such therapy is not appropriate for patients with lymph …

Background: The optimal management of high-grade dysplasia in patients with Barrett's
esophagus is controversial. The aim of this study was to assess the prevalence of …